Elan Pharmaceuticals has reported promising results in a 12-week trial of a new drug to alleviate Crohn's disease. Almost half the patients in the Antegren trial reported a remission of symptoms and muted side effects.
Promising results for Elan drug trial
Elan Pharmaceuticals has reported promising results in a 12-week trial of a new drug to alleviate Crohn's disease
IN THIS SECTION
Galway children face ‘cars travelling at 80km/h’ as walk-to-school week begins
‘My nine-year-old is starting to be self conscious about her body, which worries me’
Goodbye BMI, hello BRI: Is roundness a better measure of health than mass?
Some people believe animals should have political representation. But which animals?
All in the Game: Blunty McBluntface racks up the likes for James Blunt
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning